Basic information Safety Supplier Related
ChemicalBook >  Product Catalog >  Biochemical Engineering >  Biochemical Reagents >  Agonist Inhibitors >  Acelarin

Acelarin

Basic information Safety Supplier Related

Acelarin Basic information

Product Name:
Acelarin
Synonyms:
  • Acelarin
  • N-(2'-Deoxy-2',2'-difluoro-P-phenyl-5'-cytidylyl)-L-alanine phenylmethyl ester
  • NUC-1031
  • NUC-1031 impurity
  • N-(2'-Deoxy-2',2'-difluorocytidine 5'-P-phenyl phosphate) L-alanine benzyl ester
  • NUC-1031; NUC1031; NUC 1031
  • L-Alanine, N-(2'-deoxy-2',2'-difluoro-P-phenyl-5'-cytidylyl)-, phenylmethyl ester
  • Acelarin(NUC1031)
CAS:
840506-29-8
MF:
C25H27F2N4O8P
MW:
580.47
Mol File:
840506-29-8.mol
More
Less

Acelarin Chemical Properties

Boiling point:
708.4±70.0 °C(Predicted)
Density 
1.51±0.1 g/cm3(Predicted)
storage temp. 
Store at -20°C
solubility 
DMF: 12 mg/mL; DMSO: 14 mg/mL; DMSO:PBS (pH 7.2) (1:1): 0.5 mg/mL; Ethanol: 10 mg/mL
form 
A crystalline solid
pka
11.46±0.70(Predicted)
color 
White to off-white
InChIKey
NHTKGYOMICWFQZ-KKQYNPQSSA-N
More
Less

Acelarin Usage And Synthesis

Uses

Acelarin is a phosphoramidate transformation of the pancreatic and ovarian cancer chemotherapy Gemcitabine; and the first anti-cancer ProTide to enter the clinic.

in vivo

The ProTide demonstrates a significant reduction in tumor size against pancreatic xenograft models compared with the gemcitabine treated group, and less adverse effects on body weight, indicating a better safety profile. Data strongly suggests that the ProTides are not reliant on kinases or nucleoside transporters to exert their activity inside tumor cells and remain stable in the presence of deaminases. The ProTide NUC-1031 is currently advancing through phase I/II clinical studies and has already generated strong pharmacokinetic data that confirm significantly higher intracellular levels of gemcitabine triphosphate, together with promising early efficacy signals and a favorable safety profile. The phosphoramidate chemistry is potentially a great source of new and very effective anticancer agents, bringing a considerable array of advanced treatments specifically designed to overcome cancer resistance mechanisms that will benefit a greater proportion of patients[1].

AcelarinSupplier

Shanghai Boyle Chemical Co., Ltd.
Tel
Email
sales@boylechem.com
Shanghai Lollane Biological Technology Co.,Ltd.
Tel
021-52996696,15000506266 15000506266
Lianyungang TengFa Biological Technology Co. Ltd
Tel
0518-85475186 18705131893
Email
wang666xt@163.com
Chengdu DingDang Pharmaceutical Co., Ltd.
Tel
028-86040038 13980902949;
Email
market@dingdangchem.com
Shanghai YuanYe Biotechnology Co., Ltd.
Tel
021-61312847; 18021002903
Email
3008007409@qq.com
More
Less

Acelarin(840506-29-8)Related Product Information